About
Enzymit is ushering in a new era of bioproduction through the creation of novel enzymes that address unmet market needs. They are building a cell-free production platform to make bioproduction cheap, efficient, and localized, leveraging expertise and technological capabilities to create new biomolecular components vital for advancing markets such as biochemicals, food and beverages, personal care, and health and nutrition. Their proprietary enzyme design platform utilizes advanced computational and deep learning algorithms for highly efficient cell-free manufacturing solutions.
Key facts
At-a-glance profile data
- Website
- enzymit.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2020
- Employees
- 26
- Total funding
- $10M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 25 Sept 2024 | Series A | $10M | Grove Ventures, Nabeel Quryshi |
Tech stack
Detected on enzymit.com, last scanned 22 Sept 2026. Run your own scan
- Email provider
- Google Workspace
Frequently asked
How much funding has Enzymit raised?
Enzymit has raised a total of $10M in funding. The most recent round on record is Series A.
How many employees does Enzymit have?
Enzymit has approximately 26 people on record.

